FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

MolecuLightDX-FDA

More Like This

PR Newswire associated0

Auto Depth Digital Wound Measurement Now Available on MolecuLightDX

PR Newswire associated0

MolecuLight Announces Integration with Intellicure Electronic Health Record (EHR) for Seamless Data and Image Transfer

PR Newswire associated0

MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs

PR Newswire associated0

MolecuLight Unveils Thermal Imaging for DX™ Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring

PR Newswire associated0

MolecuLight Showcases 10 Scientific Posters at SAWC Fall and Announces Upcoming Oxygenation Imaging on the MolecuLightDX®+ Platform

PR Newswire associated0

MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association (EWMA) 2024 Annual Conference

PR Newswire associated0

Landmark Study Affirms MolecuLight's Efficacy in Real-Time Bacterial Detection for Improved Wound Management

MolecuLight Clinical Research Featured at the Upcoming SAWC Spring 2024 Conference